FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377261711> ?p ?o ?g. }

• W4377261711 endingPage "101998" @default.
• W4377261711 startingPage "101998" @default.
• W4377261711 abstract "BackgroundDifficult airway management remains a critical procedure with life-threatening adverse events. Current guidelines suggest high-flow therapy by nasal cannulae (HFNC) as a preoxygenation device in this setting. However, there is an evidence gap to support this recommendation.MethodsThe PREOPTI-DAM study is an open-label, single-centre, randomised controlled phase 3 trial done at Nantes University Hospital, France. Patients were aged 18–90 years with one major or two minor criteria of anticipated difficult airway management, and requiring intubation for scheduled surgery, were eligible. Patients with body mass index >35 kg/m2 were excluded. Patients were randomly allocated (1:1) to receive 4-min preoxygenation by HFNC or facemask. Randomisation was stratified according to the intubation strategy (laryngoscopic versus fiberoptic intubation). The primary outcome was the incidence of oxygen desaturation ≤94% or of bag-mask ventilation during intubation. The primary and safety analyses included the intention to treat population. This trial is registered with ClinicalTrials.gov (NCT03604120) and EudraCT (2018-A00434-51).FindingsFrom September 4 2018 to March 31 2021, 186 patients were enrolled and randomly assigned. One participant withdrew consent and 185 (99.5%) were included in the primary analysis (HFNC, N = 95; Facemask, N = 90). The incidence of the primary outcome was not significantly different between the HFNC and the facemask groups, respectively 2 (2%) versus 7 (8%); adjusted difference, −5.6 [95% confidence interval (CI), −11.8 to 0.6], P = 0.10. In the HFNC group, 76 patients (80%) versus 53 (59%) in the facemask group, reported good or excellent intubation experiences; adjusted difference 20.5 [95% CI, 8.3–32.8], P = 0.016. Comparing HFNC with facemask, severe complication occurred in 22 (23%) versus 27 (30%) patients (P = 0.29), and moderate complication in 14 (15%) versus 18 (20%) patients (P = 0.35). No death or cardiac arrest occurred during the study.InterpretationCompared with facemask, HFNC did not significantly reduce the incidence of desaturation ≤94% or bag-mask ventilation during anticipated difficult intubation but the trial was underpowered to rule out a clinically significant benefit. Patient satisfaction was improved with HFNC.FundingNantes University Hospital and Fisher & Paykel Healthcare." @default.
• W4377261711 created "2023-05-23" @default.
• W4377261711 creator A5006907844 @default.
• W4377261711 creator A5013841545 @default.
• W4377261711 creator A5020153865 @default.
• W4377261711 creator A5033913673 @default.
• W4377261711 creator A5047260851 @default.
• W4377261711 creator A5062899616 @default.
• W4377261711 creator A5070261387 @default.
• W4377261711 creator A5071434798 @default.
• W4377261711 creator A5073305535 @default.
• W4377261711 creator A5078571305 @default.
• W4377261711 creator A5082706504 @default.
• W4377261711 creator A5086432297 @default.
• W4377261711 creator A5091996605 @default.
• W4377261711 date "2023-06-01" @default.
• W4377261711 modified "2023-10-01" @default.
• W4377261711 title "High-flow oxygen therapy versus facemask preoxygenation in anticipated difficult airway management (PREOPTI-DAM): an open-label, single-centre, randomised controlled phase 3 trial" @default.
• W4377261711 cites W1494590553 @default.
• W4377261711 cites W1757861364 @default.
• W4377261711 cites W1940180673 @default.
• W4377261711 cites W1988890211 @default.
• W4377261711 cites W1989941075 @default.
• W4377261711 cites W1999204283 @default.
• W4377261711 cites W2036078727 @default.
• W4377261711 cites W2041921583 @default.
• W4377261711 cites W2105824687 @default.
• W4377261711 cites W2106709024 @default.
• W4377261711 cites W2108923454 @default.
• W4377261711 cites W2125564244 @default.
• W4377261711 cites W2132340127 @default.
• W4377261711 cites W2145683443 @default.
• W4377261711 cites W2173578770 @default.
• W4377261711 cites W2313356342 @default.
• W4377261711 cites W2345921706 @default.
• W4377261711 cites W2606992459 @default.
• W4377261711 cites W2771181037 @default.
• W4377261711 cites W2804933569 @default.
• W4377261711 cites W2907433305 @default.
• W4377261711 cites W2914735519 @default.
• W4377261711 cites W2940884126 @default.
• W4377261711 cites W2948322904 @default.
• W4377261711 cites W4225000349 @default.
• W4377261711 doi "https://doi.org/10.1016/j.eclinm.2023.101998" @default.
• W4377261711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37251624" @default.
• W4377261711 hasPublicationYear "2023" @default.
• W4377261711 type Work @default.
• W4377261711 citedByCount "0" @default.
• W4377261711 crossrefType "journal-article" @default.
• W4377261711 hasAuthorship W4377261711A5006907844 @default.
• W4377261711 hasAuthorship W4377261711A5013841545 @default.
• W4377261711 hasAuthorship W4377261711A5020153865 @default.
• W4377261711 hasAuthorship W4377261711A5033913673 @default.
• W4377261711 hasAuthorship W4377261711A5047260851 @default.
• W4377261711 hasAuthorship W4377261711A5062899616 @default.
• W4377261711 hasAuthorship W4377261711A5070261387 @default.
• W4377261711 hasAuthorship W4377261711A5071434798 @default.
• W4377261711 hasAuthorship W4377261711A5073305535 @default.
• W4377261711 hasAuthorship W4377261711A5078571305 @default.
• W4377261711 hasAuthorship W4377261711A5082706504 @default.
• W4377261711 hasAuthorship W4377261711A5086432297 @default.
• W4377261711 hasAuthorship W4377261711A5091996605 @default.
• W4377261711 hasBestOaLocation W43772617111 @default.
• W4377261711 hasConcept C105922876 @default.
• W4377261711 hasConcept C120665830 @default.
• W4377261711 hasConcept C121332964 @default.
• W4377261711 hasConcept C126322002 @default.
• W4377261711 hasConcept C141071460 @default.
• W4377261711 hasConcept C168563851 @default.
• W4377261711 hasConcept C197934379 @default.
• W4377261711 hasConcept C203092338 @default.
• W4377261711 hasConcept C2778716859 @default.
• W4377261711 hasConcept C2780630273 @default.
• W4377261711 hasConcept C2780978852 @default.
• W4377261711 hasConcept C2908647359 @default.
• W4377261711 hasConcept C42219234 @default.
• W4377261711 hasConcept C44249647 @default.
• W4377261711 hasConcept C61511704 @default.
• W4377261711 hasConcept C71924100 @default.
• W4377261711 hasConcept C99454951 @default.
• W4377261711 hasConceptScore W4377261711C105922876 @default.
• W4377261711 hasConceptScore W4377261711C120665830 @default.
• W4377261711 hasConceptScore W4377261711C121332964 @default.
• W4377261711 hasConceptScore W4377261711C126322002 @default.
• W4377261711 hasConceptScore W4377261711C141071460 @default.
• W4377261711 hasConceptScore W4377261711C168563851 @default.
• W4377261711 hasConceptScore W4377261711C197934379 @default.
• W4377261711 hasConceptScore W4377261711C203092338 @default.
• W4377261711 hasConceptScore W4377261711C2778716859 @default.
• W4377261711 hasConceptScore W4377261711C2780630273 @default.
• W4377261711 hasConceptScore W4377261711C2780978852 @default.
• W4377261711 hasConceptScore W4377261711C2908647359 @default.
• W4377261711 hasConceptScore W4377261711C42219234 @default.
• W4377261711 hasConceptScore W4377261711C44249647 @default.
• W4377261711 hasConceptScore W4377261711C61511704 @default.
• W4377261711 hasConceptScore W4377261711C71924100 @default.
• W4377261711 hasConceptScore W4377261711C99454951 @default.
• W4377261711 hasLocation W43772617111 @default.

• next